Abstract
Women living in rural areas of the U.S. face disparities in screening mammography and breast cancer outcomes. We sought to evaluate utilization of mammography, awareness of screening guidelines, and attitudes towards screening among rural insured U.S. women. We conducted a cross-sectional self-administered anonymous survey among 2000 women aged 40–64 insured by the National Rural Electric Cooperative Association, a non-profit insurer for electrical utility workers in predominantly rural areas across the U.S. Outcomes included mammographic screening in the past year, screening interval, awareness of guidelines, and perceived barriers to screening. 1588 women responded to the survey (response rate 79.4 %). 74 % of respondents lived in a rural area. Among women aged 40–49, 66.5 % reported mammographic screening in the past year. 46 % received annual screening, 32 % biennial screening, and 22 % rare/no screening. Among women aged 50–64, 77.1 % reported screening in the past year. 63 % received annual screening, 25 % biennial screening, and 12 % rare/no screening. The majority of women (98 %) believed that the mammography can find breast cancer early and save lives. Less than 1 % of younger women, and only 14 % of women over age 50 identified the recommendations of the U.S. Preventative Services Screening Task Force as the current expert recommendations for screening. Screening practices tended to follow perceived guideline recommendations. When rural U.S. women over age 40 have insurance, most receive breast cancer screening. The screening guidelines of cancer advocacy groups and specialty societies appear more influential and widely recognized than those of the U.S. preventative services taskforce.
Similar content being viewed by others
References
Beverage JN, Sissung TM, Sion AM, Danesi R, Figg WD (2007) CYP2D6 polymorphisms and the impact on tamoxifen therapy. J Pharm Sci 96(9):2224–2231
Donahue SR, Flockhart DA, Abernethy DR, Ko JW (1997) Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19. Clin Pharmacol Ther 62(5):572–577
Dowsett M, Goldhirsch A, Hayes DF, Senn HJ, Wood W, Viale G (2007) International Web-based consultation on priorities for translational breast cancer research. Breast Cancer Res 9(6):R81
Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E et al (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 19(Suppl 1):14–25
Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J et al (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658–663
Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, Payne J, Doyle G, Ahmad R (2014) Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst 106(11)
Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA (2001) Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91(9):1724–1731
Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C et al (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95(3):458–469
Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ, National Evaluation Team for Breast Cancer S (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361(9367):1411–1417
Barth RJ Jr, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP (2005) Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. AJR Am J Roentgenol 184(1):324–329
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K, International Agency for Research on Cancer Handbook Working G (2015) Breast-cancer screening–viewpoint of the IARC Working Group. N Engl J Med 372(24):2353–2358
EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717
Eisinger F (2008) CYP2D6 and Ockham’s razor. J Clin Oncol 26(4):686–687 (author reply 687)
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151(10):727–737
Partridge AH, Winer EP (2009) On mammography–more agreement than disagreement. N Engl J Med 361(26):2499–2501
Kopans DB (2015) An open letter to panels that are deciding guidelines for breast cancer screening. Breast Cancer Res Treat 151(1):19–25
Purc-Stephenson RJ, Gorey KM (2008) Lower adherence to screening mammography guidelines among ethnic minority women in America: a meta-analytic review. Prev Med 46(6):479–488
Onitilo AA, Engel JM, Liang H, Stankowski RV, Miskowiak DA, Broton M (2013) Doi SA Mammography utilization: patient characteristics and breast cancer stage at diagnosis. AJR Am J Roentgenol 201(5):1057–1063
Paskett ED, Tatum C, Rushing J, Michielutte R, Bell R, Foley KL, Bittoni M, Dickinson S (2004) Racial differences in knowledge, attitudes, and cancer screening practices among a triracial rural population. Cancer 101(11):2650–2659
Nguyen-Pham S, Leung J, McLaughlin D (2014) Disparities in breast cancer stage at diagnosis in urban and rural adult women: a systematic review and meta-analysis. Ann Epidemiol 24(3):228–235
Singh GK, Williams SD, Siahpush M, Mulhollen A (2011) Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I-all cancers and lung cancer and part ii-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol 2011:107497
Meissner HI, Klabunde CN, Breen N, Zapka JM (2012) Breast and colorectal cancer screening: U.S. primary care physicians’ reports of barriers. Am J Prev Med 43(6):584–589
Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM (2014) Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology 270(2):354–361
Pace LE, He Y, Keating NL (2013) Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119(14):2518–2523
U.S. Department of Agriculture Cooperative Soil Survey Regions [http://www.nrcs.usda.gov/wps/portal/nrcs/detail/soils/survey/partnership/ncss/?cid=nrcs142p2_053475]
Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM (2014) Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer. N C Med J 75(4):239–246
Feldstein AC, Perrin N, Rosales AG, Schneider J, Rix MM, Keels K, Schoap S, Glasgow RE (2009) Effect of a multimodal reminder program on repeat mammogram screening. Am J Prev Med 37(2):94–101
Hegenscheid K, Hoffmann W, Fochler S, Domin M, Weiss S, Hartmann B, Bick U, Hosten N (2011) Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial. Am J Prev Med 41(4):421–427
Kelaher M, Cawson J, Miller J, Kavanagh A, Dunt D, Studdert DM (2008) Use of breast cancer screening and treatment services by Australian women aged 25–44 years following Kylie Minogue’s breast cancer diagnosis. Int J Epidemiol 37(6):1326–1332
Acknowledgments
This study was supported by a Research Scholar grant from the American Cancer Society (JP).
Authors Contributions
All authors contributed to the conception or design of this study, analysis of data, and drafting or review of the manuscript. All authors reviewed and approved the final submitted version of this manuscript.
Disclosures
JP has served as a consultant for Genentech, and JP’s spouse is employed by GlaxoSmithKline.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Peppercorn, J., Houck, K., Beri, N. et al. Breast cancer screening utilization and understanding of current guidelines among rural U.S. women with private insurance. Breast Cancer Res Treat 153, 659–667 (2015). https://doi.org/10.1007/s10549-015-3566-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-015-3566-1